Tokyo, March 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060892) titled 'The diagnostic yield of malignant lymphoma by convex-probe endobronchial ultrasound bronchoscope: a multicenter prospective observational study' on March 11.
Study Type:
Observational
Primary Sponsor:
Institute - Central Japan Lung Study Group
Condition:
Condition - Malignant lymphoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate effective methods and equipments for endobronchial ultrasound-guided biopsy targeting hilar/mediastinal lymph nodes or hilar/mediastinal lesions in clinical practice.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1. Patients with hilar/mediastinal lesions and/or lymph nodes, where malignant lymphoma lesions are considered.
2. 18 years or older
3. Informed consent
Key exclusion criteria - 1. Patients who are already diagnosed malignant lymphoma pathologically by other lesions.
Target Size - 60
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 02 Month 14 Day
Date of IRB - 2026 Year 03 Month 09 Day
Anticipated trial start date - 2026 Year 03 Month 11 Day
Last follow-up date - 2029 Year 09 Month 11 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069577
Disclaimer: Curated by HT Syndication.
